by PerkinElmer
These columns are made on High-purity, Type B silica. It exhibits excellent peak shape for a wide range of compounds while also having a wide number of phases. The Brownlee Validated columns are the best choice for pharmaceutical applications that deal with a lot of basic or multi-functional compounds. Columns are available in 3 or 5 µ and lengths ranging from 30-250 mm, in 2.1 and 4.6 i.d., and include Amino, C18, C8, Carbamate, Cyano, IBD (intrinsically base-deactivated), PFP (pentafluorophenyl) and phenyl phases.
Excellent general purpose phase column. Retentive high purity packing.
| Vendor | PerkinElmer | Length | |
| Brand | Brownlee Validated C18 | Internal Diameter | |
| Modifification | Silica/C18 | Pore size | 100 |
| Mode | Reversed-Phase | Carbon Load, % | 20.0 |
| Particle Size | Endcapped | Yes |
| Vendor | Brand | Mode | Modification | Int. diam. | Length | Particles | Pores | Price |
|---|---|---|---|---|---|---|---|---|
| Teknokroma | Hyperpack BASIC ODS | Reversed-Phase | Silica/C18 | 3.0 mm | 30 mm | 5.0 μm | 130 Å | On request |
| GL Sciences | Inertsil ODS-EP | Reversed-Phase | Silica/C18 | 2.0 mm | 100 mm | 5.0 μm | 100 Å | On request |
| Imtakt | Unison UK-C18 | Reversed-Phase | Silica/C18 | 2.0 mm | 150 mm | 3.0 μm | 130 Å | On request |
| Agilent Technologies | ZORBAX Eclipse Plus | Reversed-Phase | Silica/C18 | 3.0 mm | 150 mm | 1.8 μm | 95 Å | On request |
| Agilent Technologies | ZORBAX Eclipse XDB | Reversed-Phase | Silica/C18 | 2.0 mm | 150 mm | 1.8 μm | 80 Å | On request |
| BISCHOFF | ProntoSIL 60-5-C18 H | Reversed-Phase | Silica/C18 | 4.6 mm | 250 mm | 5.0 μm | 60 Å | On request |
| Phenomenex | HyperClone | Reversed-Phase | Silica/C18 | 2.0 mm | 250 mm | 5.0 μm | 120 Å | On request |
| BISCHOFF | ProntoSIL 120-5-C18 SH PEEK | Reversed-Phase | Silica/C18 | 4.0 mm | 200 mm | 5.0 μm | 120 Å | On request |
No customer reviews yet. Be the first to share your experience!
Reach thousands of researchers worldwide. Fill in your details and our team will contact you shortly.
